These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 19616482)

  • 41. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF; Banerjee S; Brabant Y; Helmers S
    Epilepsy Behav; 2009 Oct; 16(2):240-5. PubMed ID: 19699156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Status epilepticus in idiopathic generalized epilepsy.
    Shorvon S; Walker M
    Epilepsia; 2005; 46 Suppl 9():73-9. PubMed ID: 16302878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
    Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
    Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypersomnia in an epilepsy patient treated with levetiracetam.
    Khatami R; Siegel AM; Bassetti CL
    Epilepsia; 2005 Apr; 46(4):588-9. PubMed ID: 15816957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
    Alvarez V; Januel JM; Burnand B; Rossetti AO
    Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.
    Nakamura K; Inokuchi R; Daidoji H; Naraba H; Sonoo T; Hashimoto H; Tokunaga K; Hiruma T; Doi K; Morimura N
    Medicine (Baltimore); 2017 Jun; 96(25):e7206. PubMed ID: 28640109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
    Abend NS; Monk HM; Licht DJ; Dlugos DJ
    Pediatr Crit Care Med; 2009 Jul; 10(4):505-10. PubMed ID: 19325512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
    Brodtkorb E; Klees TM; Nakken KO; Lossius R; Johannessen SI
    Epilepsy Behav; 2004 Apr; 5(2):231-5. PubMed ID: 15123025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous lacosamide in status epilepticus and seizure clusters.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsia; 2011 Oct; 52(10):e148-52. PubMed ID: 21801171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.
    Weber P
    J Child Neurol; 2010 Mar; 25(3):393-6. PubMed ID: 19605773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experience with intravenous levetiracetam in status epilepticus: a retrospective case series.
    Gámez-Leyva G; Aristín JL; Fernández E; Pascual J
    CNS Drugs; 2009 Nov; 23(11):983-7. PubMed ID: 19845418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy.
    Piazzini A; Chifari R; Canevini MP; Turner K; Fontana SP; Canger R
    Epilepsy Res; 2006 Mar; 68(3):181-8. PubMed ID: 16332430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus.
    Knake S; Gruener J; Hattemer K; Klein KM; Bauer S; Oertel WH; Hamer HM; Rosenow F
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):588-9. PubMed ID: 17898030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Non-convulsive epileptic status reverted with intravenous levetiracetam].
    Callén-Soto A; Pérez-Pérez S; Robles-Del Olmo B
    Rev Neurol; 2008 Nov 1-15; 47(9):501-2. PubMed ID: 18985603
    [No Abstract]   [Full Text] [Related]  

  • 58. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
    Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
    Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
    Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
    Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.